Skip to main content
. Author manuscript; available in PMC: 2020 Aug 15.
Published in final edited form as: Life Sci. 2019 Jun 14;231:116571. doi: 10.1016/j.lfs.2019.116571

Fig. 1.

Fig. 1.

CDKN2B-AS1 is decreased in whole colon biopsies from actively inflamed ulcerative colitis patients. (a) Heat map representation of microarray results of CDKN2B-AS1 levels in IBD patients or controls. (b) qPCR validation of the alterations in CDKN2B-AS1 RNA levels in ulcerative colitis patients compared to controls. Mean ± SEM. For the validation n = 10 samples per group. For the microarray n = 7–8 samples per group. * p < 0.05.